Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Latanoprost, a glaucoma medication, caused excessive eyelid hair growth in many patients.

There are potential treatments for pattern baldness, but more research is needed to confirm their effectiveness.

Topical latanoprost doesn't effectively regrow hair in severe eyebrow alopecia areata cases.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

sPLA2-X is crucial for normal hair growth and follicle health.

Madarosis is the loss of eyelashes and eyebrows due to various health issues and requires thorough examination to diagnose and treat the underlying cause.

LPA3 is crucial for embryo implantation and links LPA to prostaglandin signaling.

Wnt3a activates certain genes in hair follicle cells, including a newly discovered one, EP2, which may affect hair growth.

Bimatoprost can cause longer, thicker, darker eyelashes and eyebrows.

Latanoprost may cause scalp inflammation and delayed healing.

Travoprost can help eyelash growth but may cause darkening around the eyes.

Latanoprost, a glaucoma treatment, was found ineffective in treating hair loss in eyebrows and eyelashes.

Some alternative vitiligo treatments show promise, but none are as effective as psoralens and UVA.

Annurca apple extract may protect mouse hair from damage by chemotherapy and could help treat hair loss without promoting cancer growth.

Intralesional corticosteroids work best for mild alopecia areata, and DPCP works best for moderate to severe cases.

Alopecia areata can be managed with various treatments, and severe cases should be referred to dermatologists.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

The document concludes that modern ocular cosmetics enhance beauty and eyelash health, with safe practices and regulations being important.

The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.

The symposium concluded that understanding the molecular mechanisms of skin aging could lead to better clinical practices and treatments.

Latanoprost eye drops may cause skin depigmentation.

Bimatoprost eye drops can cause temporary eyelid changes and may help with hair growth research.

Certain chemicals cause hair graying in black mice but not yellow mice.

UV light might cause excessive hair growth by increasing PGE2 in the skin.

Latanoprost eye drops caused excessive hair growth and eyelash whitening in a woman.

Injected bimatoprost 0.03% solution did not effectively treat female-pattern hair loss.

Prostaglandins may protect hair follicles during chemotherapy.

Minoxidil promotes hair growth but exact mechanism is unknown.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.